Phenotypic characterization of nanshi oral liquid alters metabolic signatures during disease prevention

Scientific Reports

Volumn 6, Issue , 2016, Pages

  Zhang, Aihua ^a   Liu, Qi ^a   Zhao, Hongwei ^b   Zhou, Xiaohang ^a   Sun, Hui ^a   Nan, Yang ^a   Zou, Shiyu ^b   Ma, Chung Wah ^b   Wang, Xijun ^a  

^a HEILONGJIANG UNIVERSITY OF CHINESE MEDICINE   (China)

^b Infinitus (China) Company Ltd   (China)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; HERBACEOUS AGENT;

ANIMAL; CHINESE MEDICINE; DISEASE MODEL; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; KIDNEY DISEASES; MALE; MASS SPECTROMETRY; METABOLISM; METABOLOME; METABOLOMICS; PATHOLOGY; PRINCIPAL COMPONENT ANALYSIS; PROCEDURES; RAT; SYNDROME; YANG DEFICIENCY;

ANIMALS; BIOMARKERS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DISEASE MODELS, ANIMAL; DRUGS, CHINESE HERBAL; HUMANS; KIDNEY DISEASES; MALE; MASS SPECTROMETRY; MEDICINE, CHINESE TRADITIONAL; METABOLIC NETWORKS AND PATHWAYS; METABOLOME; METABOLOMICS; PRINCIPAL COMPONENT ANALYSIS; RATS; SYNDROME; YANG DEFICIENCY;

EID: 84955062815     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep19333     Document Type: Article

References (45)

1. Sreekumar, A. et al. Metabolomic profiles delineate potential role for sarcosine in prostate cancer progression. Nature 457, 910-914 (2009).
2. Zhang, A., Sun, H., Wang, X. Potentiating therapeutic effects by enhancing synergism based on active constituents from traditional medicine. Phytotherapy Research 28, 526-533 (2014).
3. Arakaki, A. K. et al. Marker metabolites can be therapeutic targets as well. Nature 456, 443 (2008).
4. Rochfort, S. Metabolomics reviewed: a new "omics" platform technology for systems biology and implications for natural products research. Journal of natural products 68(12), 1813-1820 (2005).
5. Sun, H., Zhang, A., Wang, X. Potential role of metabolomic approaches for Chinese medicine syndromes and herbal medicine. Phytotherapy Research 26, 1466-1471 (2012).
6. Wang, X. et al. Potential role of metabolomics apporoaches in the area of traditional Chinese medicine:as pillars of the bridge between Chinese and Western medicine. Journal of pharmaceutical and biomedical analysis 55, 859-868 (2011).
7. Beckonert, O. et al. Metabolic profiling, metabolomic and metabonomic procedures for NMR spectroscopy of urine, plasma, serum and tissue extracts. Nature protocols 2, 2692-2703 (2007).
8. Want, E. J. et al. Global metabolic profiling procedures for urine using UPLC-MS. Nature protocols 5, 1005-1018 (2010).
9. Want, E. J. et al. Global metabolic profiling of animal and human tissues via UPLC-MS. Nature protocols 8, 17-32 (2013).
10. Zhang, A., Sun, H., Wang, X. Urinary metabolic profiling of rat models revealed protective function of scoparone against alcohol induced hepatotoxicity. Sci Rep 4, 6768 (2014).
11. Moraes, E. P. et al. Metabolomic assessment with CE-MS of the nutraceutical effect of Cystoseira spp extracts in an animal model. Electrophoresis 32, 2055-2062 (2011).
12. Ramautar, R. et al. CE-MS in metabolomics. Electrophoresis 30, 276-291 (2009).
13. Chen, J. et al. Combined Application of NMR-and GC-MS-Based Metabonomics Yields a Superior Urinary Biomarker Panel for Bipolar Disorder. Sci Rep 4, 5855 (2014).
14. Pacini, T., Fu, W., Gudmundsson, S. A multidimensional analytical approach based on UHPLC-UV-ion mobility-MS for the screening of natural pigments. Analytical chemistry 87, 2593-2599 (2015).
15. Atrih, A. et al. Quantitative proteomics in resected renal cancer tissue for biomarker discovery and profiling. British journal of cancer 110, 1622-1633 (2014).
16. Barbara, J. E., High-resolution, M. S.: software, data processing and data management. Future Medicine. 74-91 (2014).
17. Yan, G. et al. Dissection of biological property of Chinese acupuncture point zusanli based on long-term treatment via modulating multiple metabolic pathways. Evid Based Complement Alternat Med 2013, 429703 (2013).
18. Zhang, A. et al. Metabolomics: towards understanding traditional Chinese medicine. Planta medica. 76, 2026 (2010).
19. Qi, Y. et al. Metabolomics study of resina draconis on myocardial ischemia rats using ultraperformance liquid chromatography/quadrupole time-of-flight mass spectrometry combined with pattern recognition methods and metabolic pathway analysis. Evid Based Complement Alternat Med. 2013, 438680 (2013).
20. Yang, B. et al. Metabolomic study of insomnia and intervention effects of Suanzaoren decoction using ultra-performance liquidchromatography/electrospray-ionization synapt high-definition mass spectrometry. Journal of pharmaceutical and biomedical analysis 58, 113-124 (2012).
21. Tsai, D. et al. Metabolomic analysis of complex Chinese remedies:examples of induced nephrotoxicity in the mouse from a series of remedies containing aristolochic acid. Evid Based Complement Alternat Med 2013, 263757 (2013).
22. Unschuld, P. U. "Huang Di Nei Jing Su Wen": Nature, Knowledge, Imagery in an Ancient Chinese Medical Text: With an Appendix: The Doctrine of the Five Periods and Six Qi in the Huang Di Nei Jing Su Wen. Univ of California Press (2003).
23. Huang, D. et al. An integrated plasma and urinary metabonomic study using UHPLC-MS: Intervention effects of Epimedium koreanum on 'Kidney-Yang Deficiency syndrome'rats. Journal of pharmaceutical and biomedical analysis 76, 200-206 (2013).
24. Zhao, L. et al. Metabolic Signatures of Kidney Yang Deficiency Syndrome and Protective Effects of Two Herbal Extracts in Rats Using GC/TOF MS. Evid Based Complement Alternat Med 2013, 540957 (2013).
25. Wang, C. et al. Curculigo orchioides (Xian Mao) modifies the activity and protein expression of CYP3A in normal and Kidney-Yang Deficiency model rats. Journal of Ethnopharmacology 144, 33-38 (2012).
26. Lu, X. et al. Metabonomic study on 'Kidney-Yang Deficiency syndrome'and intervention effects of Rhizoma Drynariae extracts in rats using ultra performance liquid chromatography coupled with mass spectrometry. Talanta 83, 700-708 (2011).
27. Yang, J. et al. The total flavones from Semen cuscutae reverse the reduction of testosterone level and the expression of androgen receptor gene in kidney-yang deficient mice. Journal of ethnopharmacology 119(1), 166-171 (2008).
28. Zhang, A. et al. Future perspectives of personalized medicine in traditional Chinese medicine: a systems biology approach. Complementary therapies in medicine 20, 93-99 (2012).
29. Tan, Y. et al. Metabolic profiling reveals therapeutic biomarkers of processed Aconitum Carmichaeli Debx in treating hydrocortisone induced Kidney-Yang deficiency syndrome rats. Journal of ethnopharmacology 152, 585-593 (2014).
30. Yang, J. et al. The total flavones from Semen cuscutae reverse the reduction of testosterone level and the expression of androgen receptor gene in kidney-yang deficient mice. Journal of ethnopharmacology 119, 166-171 (2008).
31. Wang, X. et al. Potential role of metabolomics apporoaches in the area of traditional Chinese medicine:as pillars of the bridge between Chinese and Western medicine. Journal of pharmaceutical and biomedical analysis 55, 859-868 (2011).
32. Guchhait, R. B. et al. Validity of plasma factor in schizophrenia as measured by tryptophan uptake. Biological psychiatry 10(3), 303-314 (1975).
33. Sjoberg, S. et al. L-thyroxine treatment and neurotransmitter levels in the cerebrospinal fluid of hypothyroid patients: a pilot study. European journal of endocrinology 139, 493-497 (1998).
34. Pawlak, D. et al. Tryptophan metabolism via the kynurenine pathway in experimental chronic renal failure. Nephron 90, 328-335 (2002).
35. Zhao, Y. Metabolomics in chronic kidney disease. Clinica Chimica Acta. 422, 59-69 (2013).
36. Iuvone, P. M. et al. N-acetylserotonin:circadian activation of the BDNF receptor and neuroprotection in the retina and brain. Retinal Degenerative Diseases, Springer, 765-771 (2014).
37. Oxenkrug, G. Antioxidant Effects of N-Acetylserotonin. Annals of the New York Academy of Sciences 1053, 334-347 (2005).
38. Ripps, H., Shen, W. Review: taurine:a "very essential" amino acid. Molecular vision 18, 2673 (2012).
39. Wu, J. GABA and taurine enzymes in mammalian brain. Enzyme Catalysis and Control: Current Topics in Cellular Regulation 24, 119 (2014).
40. Mu, T. et al. Effect of Taurine on Reproductive Hormone Secretion in Female Rats. Taurine 9, Springer, 449-456 (2015).
41. Chesney, R. W. et al. Newer Insights into the Taurinuria of Vitamin D Deficiency: A Review. Taurine 9, Springer, 651-664 (2015).
42. Hiroi, T. et al. Dopamine formation from tyramine by CYP2D6. Biochemical and biophysical research communications 249, 838-843 (1998).
43. Lindemann, L., Hoener, M. C. A renaissance in trace amines inspired by a novel GPCR family. Trends in pharmacological sciences 26, 274-281 (2005).
44. Broadley, K. J. The vascular effects of trace amines and amphetamines. Pharmacology & therapeutics 125, 363-375 (2010).
45. Kirkegaard, C., Faber, J. The role of thyroid hormones in depression. European Journal of Endocrinology 138, 1-9 (1998).